PE Hub Wire

Investor group buys majority stake in Centene's USMM, MiddleGround doubles down on auto-industry deals, PE firms make hybrid return to office

Value-based care flurry continues: Investor group buys majority of Centene's USMM.

Investing in growth: Oak HC/FT backs Infusion for Health, FTV brings Vagaro's valuation to $1bn

Oak HC/FT backs Infusion for Health and FTV investment values Vagaro at $1bn.

Rewiring healthcare: value-based care incites groundswell of investment; GTCR buys Cisive

Value-based care emerges as must-have for investors,

Carlyle joins Warburg as investor in Duravant, Linden preps 2022 sale of Evolution Research Group

Busted processes haunt investors in crowded M&A market.

T. Rowe Price agrees to acquire Oak Hill Advisors, NewSpring Capital runs process to more time, capital for Verisma

T. Rowe Price agreed to acquire Oak Hill Advisors for up to $4.2 billion.

Centerbridge, Vistria seek minority stake sale of Sevita ahead of GP-led deal, Bain Capital invests in Cardurion Pharmaceuticals and Gluware

Bain Capital makes two investments.

Shore Capital explores sale of Mission Veterinary Partners, two execs from Shamrock raising debut fund

Shore Capital Partners is considering a sale of Mission Veterinary Partners and Coral Tree targets $350 million for inaugural fund.

Wellspring clinches third home care deal with Caring Brands, H&F and EQT jointly bid for Zooplus, VSS makes 3x-plus on Coretelligent

Wellspring acquires Caring Brands while H&F and EQT jointly pursue Zooplus.

EyeCare Partners inks $600m add-on, Partners Group bans 'deal' terminology, Blue Wolf carves out CIVCO Radiotherapy from Roper

Partners' EyeCare Partners buys Revelstoke's CVP while Blue Wolf buys Roper's radiotherapy arm.

ICV generates 6x return on sale of Outpatient Imaging Affiliates, Private equity gets skewered in Warren-led Senate hearing

Private equity may be set for big changes as a result of a congressional bill.